Lee T. Schaller
Research Triangle Park Foundation(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, Biochemical and Molecular Research, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor(2005)168 cited
- → The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral(2007)74 cited
- → Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1(2004)65 cited
- → Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor(2005)62 cited
- → Design of Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase with Improved Drug Resistance Properties. 2.(2004)62 cited
- → Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs)(2015)32 cited
- → Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate Viruses and In Vitro Selection for Resistance(2005)27 cited
- → An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model(2018)26 cited
- → The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors(2019)23 cited
- → N-Hydroxyformamide peptidomimetics as TACE/Matrix metalloprotease inhibitors: oral activity via P1′ isobutyl substitution(2001)21 cited